Byome Labs Raises €3.6M To Expand Skin Microbiome Technology For Personalized Skincare

The funding will support industrial production of Byome Derma, a skin test that provides personalized skincare recommendations based on each individual’s microbiome.

The solution allows skin microbiome sampling and measurement within minutes directly at the point of sale.

BYOME LABS, founded in 2023, has an R&D center in Cosmetic Valley, Chartres, studying how cosmetic products interact with the skin. Its microbiology lab helps clients with scientific expertise, marketing claims, and R&D validation, combining innovation and technology to advance microbiome research for cosmetics.

Read Also - Lightbase Raises €2.2M Pre-Seed To Launch AI-Powered Developer Platform

Designed as a white-label solution for retail, Byome Derma enables cosmetic and dermo-cosmetic brands to deliver hyper-personalized experiences backed by scientific data. Using microbial diversity analysis via antigenic strips (similar to COVID tests) and dermatologist-trained AI, it provides product recommendations without devices, pain, or high cost.

Byome Labs plans to begin industrial production of the first Byome Derma kits by year-end, with international rollout across Europe, the US, and Asia in 2026. The company also intends to expand its R&D team and open new positions next year.

“Scientific innovation only matters if it can serve the many. With this fundraising, we are scaling up to the industrial level and offering brands a new standard of instant skincare recommendations, based on biological data rather than guesswork,” said David Suissa, Founder & CEO of Byome Labs.

About BYOME LABS

BYOME LABS is an expert in microbiome testing and analysis, helping cosmetic brands understand how products interact with the skin. Their R&D and microbiology labs provide scientific expertise, support marketing claims, and validate research, combining innovation, technology and industry know-how to advance skincare solutions and personalized cosmetic experiences.